Biotechnology stocks and technology stocks experienced significant declines driven by high selling volume and company-specific news. Key factors like clinical trial data and quarterly earning

Cerebras Systems Inc. (NASDAQ: CBRS) saw its stock climb by $126.07, or 68.15%, to $311.07. The company, which specializes in AI compute platforms, recently debuted on the public market. Its initial p

Jack in the Box (NASDAQ:JACK) is navigating intense competition and weak financial results, leading to a significant stock price decline and a leadership change. Analyst firm Jefferies revise

CEO's significant insider buying suggests leadership confidence and potential undervaluation of AECOM stock. External analysis from Zacks Investment Research assigns AECOM a strong "Buy" rating (Rank

Significant Earnings Miss: Biofrontera Inc. reported a wider-than-expected quarterly loss of $0.41 per share, exceeding analyst estimates. Robust Revenue Growth: Despite the earnings miss, th

Analyst Confidence: Morgan Stanley increased its price target for Nova Ltd. (NASDAQ: NVMI) to $494.00, with the stock already trading higher at $555.79, reflecting strong investor confidence in t